findmyKOL

Yael Harris, MD

Basic profile

Northwell Health

ORCIDNPI
RegionGreat Neck, NY · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Yael Harris is an Endocrinology/Metabolic physician affiliated with Northwell Health. OpenAlex indexes 75 publications with 2,114 citations (h-index 19).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
75publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,114citations

Total citations across indexed works.

19h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

865 Northern Blvd Ste 203
Great Neck, NY 110215310

Telephone

516-708-2540

Provider last certified this registry record 19 Mar 2024.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    76.1%
    RANK Ligand Inhibitor75.6%
    Denosumab100%Prolia0%
    Part D + Part B49 patients
    Bisphosphonates0.5%
    Risedronate Sodium Dr71%Risedronate Sodium29%
    Part D<11 patients
  • Metabolism & gastrointestinal

    14.7%
    GLP-1 receptor agonist5.2%
    Ozempic48%Mounjaro33%Trulicity19%
    Part D40 patients
    Insulin Analog3.4%
    Lantus Solostar21%Basaglar Kwikpen U-10017%Novolog Flexpen16%Humalog10%Humalog Kwikpen U-1007%Insulin Lispro Kwikpen U-1006%Tresiba Flextouch U-2006%Lyumjev Kwikpen U-1006%Novolog6%Tresiba Flextouch U-1006%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    4.2%
    Statin2.3%
    Atorvastatin Calcium83%Rosuvastatin Calcium17%
    Part D42 patients
    Angiotensin receptor blocker (ARB)0.5%
    Losartan Potassium100%
    Part D12 patients

    + 4 more classes in this area

Where care is delivered (Part B)0.8% facility · 99.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”